SUPRIYA LIFESCIENCE
Back to Cashflow Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹165 Cr | ₹113 Cr | ₹64 Cr | ₹49 Cr | ₹76 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUPRIYA LIFESCIENCE ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹165 Cr |
| Mar2024 | ₹113 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹49 Cr |
| Mar2021 | ₹76 Cr |
How is Cash Flow from Operating Activities of SUPRIYA LIFESCIENCE Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹165 Cr | 45.34 | |
| Mar2024 | ₹113 Cr | 78.14 | |
| Mar2023 | ₹64 Cr | 30.34 | |
| Mar2022 | ₹49 Cr | -35.69 | |
| Mar2021 | ₹76 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,302.7 Cr | 0.5% | -6.3% | 17.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 0.5% |
-6.3% |
17.9% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses